Table 3.
Adjusted for | Group-effect p value |
---|---|
No adjustment | 0.003 |
Body composition | |
BMI | 0.005 |
Total body fat | 0.006 |
BMI and waist/hip circumference ratio | 0.007 |
Total body fat and android/gynoid ratio | 0.008 |
Fasting plasma lipoprotein-related parameters | |
Plasma cholesterol | 0.009 |
Plasma LDL-C | 0.005 |
Plasma HDL-C | 0.003 |
Plasma NEFA | 0.004 |
LOG10 plasma TG | 0.006 |
Plasma apoB | 0.079 |
Plasma PCSK9 | 0.004 |
Plasma apoB/PCSK9 | 0.029 |
Plasma LDL-C/apoB | 0.006 |
Energy intake and expenditure | |
Basal metabolic rate | 0.003 |
Daily energy intake | 0.001 |
% carbohydrate intake | 0.022 |
% fat intake | 0.011 |
% saturated fat intake | 0.005 |
LOG10 fasting baseline WAT mRNA | |
PPARG | 0.005 |
ADIPOQ | 0.002 |
HMGCR | 0.005 |
SREBP1C | 0.004 |
SREBP2 | 0.009 |
CD36 | 0.007 |
LDLR | 0.004 |
MCP1 | 0.005 |
ADGRE1 | 0.008 |
NLRP3 | 0.007 |
IL1B | 0.003 |
CASP1 | 0.002 |
IL10 | 0.005 |
Fasting baseline WAT protein | |
Pro-IL-1β | 0.003 |
% plasma phospholipid FA | |
% total saturated FA | 0.007 |
% total monounsaturated FA | 0.008 |
% total omega-3 FA | 0.007 |
% total omega-6 FA | 0.009 |
% total polyunsaturated FA | 0.009 |
Significant values are in bold.
Data analyzed by 2-way RM-ANOVA. N.B. Only subjects with complete WAT IL-1β-secretion profiles induced by the 7-incubation conditions were used in this analysis.